This content is machine translated Aspirin-free strategy after PCI No reduction in bleeding (STOPDAPT-3 study) No ESC Congress without new studies on antithrombotic therapy after percutaneous coronary intervention. Recently, monotherapy with a P2Y12 blocker has increasingly emerged as an attractive alternative to dual antiplatelet therapy…
